| Nancy Ferrara-france, FNP | |
|
1511 Daniels Ave, Altoona, WI 54720-1745 | |
| (715) 563-4016 | |
| Not Available |
| Full Name | Nancy Ferrara-france |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1511 Daniels Ave, Altoona, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033802418 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 10816-33 (Wisconsin) | Primary |
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191118000551 |
News Archive
Researchers in the United States have identified several clinically approved compounds that could be repurposed for the treatment and prevention of coronavirus disease 2019 (COVID-19).
According to a warning from the Royal College of Midwives parts of England are facing a dangerous shortage of midwives as Britain's birthrate climbs. The RCM added that while shortages are seen across the country, some areas are worse than others, putting mothers and babies at risk.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
In an interview with Reuters, Health and Human Services Secretary Kathleen Sebelius "said she is pushing [insurance] companies to help people gain insurance in the gap between now and 2014. That is when the healthcare law President Barack Obama signed in March mandates extensive changes. Sebelius struck a cooperative tone after publicly chastising insurers for high rate hikes ... and after repeatedly calling them to the White House for highly publicized talks. A more congenial relationship with insurers could help keep the major overhaul of the healthcare system on track and loosen strained relations between Democrats and big business ahead of the November midterm elections" (Richwine, 7/8).
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Ferrara-france, FNP 4055 Valley View Ln Ste 700, Dallas, TX 75244-5045 Ph: (503) 498-6757 | Nancy Ferrara-france, FNP 1511 Daniels Ave, Altoona, WI 54720-1745 Ph: (715) 563-4016 |
News Archive
Researchers in the United States have identified several clinically approved compounds that could be repurposed for the treatment and prevention of coronavirus disease 2019 (COVID-19).
According to a warning from the Royal College of Midwives parts of England are facing a dangerous shortage of midwives as Britain's birthrate climbs. The RCM added that while shortages are seen across the country, some areas are worse than others, putting mothers and babies at risk.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
In an interview with Reuters, Health and Human Services Secretary Kathleen Sebelius "said she is pushing [insurance] companies to help people gain insurance in the gap between now and 2014. That is when the healthcare law President Barack Obama signed in March mandates extensive changes. Sebelius struck a cooperative tone after publicly chastising insurers for high rate hikes ... and after repeatedly calling them to the White House for highly publicized talks. A more congenial relationship with insurers could help keep the major overhaul of the healthcare system on track and loosen strained relations between Democrats and big business ahead of the November midterm elections" (Richwine, 7/8).
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
› Verified 4 days ago
Amber Willmarth, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1451 Bluestem Blvd Ste F, Altoona, WI 54720 Phone: 715-575-5800 | |
Tracy Neises, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1411 Winchester Way Ste 7, Altoona, WI 54720 Phone: 715-313-0871 | |
Elise Jane Jensen, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1200 Oakleaf Way, Altoona, WI 54720 Phone: 715-832-1400 | |
Lia Pender, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3119 Woodman Dr, Altoona, WI 54720 Phone: 920-496-4700 | |
Jolene L. D'huyvetter, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1200 Oakleaf Way, Suite A, Altoona, WI 54720 Phone: 715-832-1400 Fax: 715-832-4187 | |
Benjamin G Anderson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1200 Oakleaf Way Ste A, Altoona, WI 54720 Phone: 715-832-1400 Fax: 715-832-4187 |